Effect of recombinant human hemoglobin on human bone marrow progenitor cells: protection and reversal of 3′ -azido-3′ -deoxythymidine-induced toxicity
- 1 April 1996
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 85 (1) , 55-62
- https://doi.org/10.1016/0378-4274(96)03640-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesisAntimicrobial Agents and Chemotherapy, 1994
- A human recombinant haemoglobin designed for use as a blood substituteNature, 1992
- Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow.The Journal of Experimental Medicine, 1990
- Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activityAntimicrobial Agents and Chemotherapy, 1988
- Hemoglobin binding to deglycosylated haptoglobinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- STUDIES ON HEMOGLOBIN METABOLISM. I. THE KINETIC PROPERTIES OF THE PLASMA HEMOGLOBIN POOL IN NORMAL MAN*Journal of Clinical Investigation, 1959
- THE EFFECT OF HEMOGLOBIN ON RENAL FUNCTION IN THE HUMANJournal of Clinical Investigation, 1951
- Clinical Experience with Hemoglobin-Saline SolutionsJournal of Applied Physiology, 1949
- BLOOD SUBSTITUTESBiological Reviews, 1937